507 related articles for article (PubMed ID: 17668910)
21. Isocratic solid phase extraction-liquid chromatography (SPE-LC) interfaced to high-performance tandem mass spectrometry for rapid protein identification.
Hørning OB; Kjeldsen F; Theodorsen S; Vorm O; Jensen ON
J Proteome Res; 2008 Aug; 7(8):3159-67. PubMed ID: 18578518
[TBL] [Abstract][Full Text] [Related]
22. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
[TBL] [Abstract][Full Text] [Related]
23. Semi-targeted plasma proteomics discovery workflow utilizing two-stage protein depletion and off-line LC-MALDI MS/MS.
Juhasz P; Lynch M; Sethuraman M; Campbell J; Hines W; Paniagua M; Song L; Kulkarni M; Adourian A; Guo Y; Li X; Martin S; Gordon N
J Proteome Res; 2011 Jan; 10(1):34-45. PubMed ID: 20936781
[TBL] [Abstract][Full Text] [Related]
24. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
25. CLUE-TIPS, clustering methods for pattern analysis of LC-MS data.
Akella LM; Rejtar T; Orazine C; Hincapie M; Hancock WS
J Proteome Res; 2009 Oct; 8(10):4732-42. PubMed ID: 19725534
[TBL] [Abstract][Full Text] [Related]
26. A statistical method for chromatographic alignment of LC-MS data.
Wang P; Tang H; Fitzgibbon MP; McIntosh M; Coram M; Zhang H; Yi E; Aebersold R
Biostatistics; 2007 Apr; 8(2):357-67. PubMed ID: 16880200
[TBL] [Abstract][Full Text] [Related]
27. Detecting differential and correlated protein expression in label-free shotgun proteomics.
Zhang B; VerBerkmoes NC; Langston MA; Uberbacher E; Hettich RL; Samatova NF
J Proteome Res; 2006 Nov; 5(11):2909-18. PubMed ID: 17081042
[TBL] [Abstract][Full Text] [Related]
28. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
[TBL] [Abstract][Full Text] [Related]
29. Detergent-free biotin switch combined with liquid chromatography/tandem mass spectrometry in the analysis of S-nitrosylated proteins.
Han P; Chen C
Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1137-45. PubMed ID: 18335467
[TBL] [Abstract][Full Text] [Related]
30. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data.
Mueller LN; Brusniak MY; Mani DR; Aebersold R
J Proteome Res; 2008 Jan; 7(1):51-61. PubMed ID: 18173218
[TBL] [Abstract][Full Text] [Related]
31. Isoform analysis of LC-MS/MS data from multidimensional fractionation of the serum proteome.
Krasnoselsky AL; Faca VM; Pitteri SJ; Zhang Q; Hanash SM
J Proteome Res; 2008 Jun; 7(6):2546-52. PubMed ID: 18419151
[TBL] [Abstract][Full Text] [Related]
32. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
33. Biomarker discovery in psychiatric disorders.
Schwarz E; Bahn S
Electrophoresis; 2008 Jul; 29(13):2884-90. PubMed ID: 18512679
[TBL] [Abstract][Full Text] [Related]
34. Data processing pipelines for comprehensive profiling of proteomics samples by label-free LC-MS for biomarker discovery.
Christin C; Bischoff R; Horvatovich P
Talanta; 2011 Jan; 83(4):1209-24. PubMed ID: 21215856
[TBL] [Abstract][Full Text] [Related]
35. Multidimensional chromatography coupled to mass spectrometry in analysing complex proteomics samples.
Horvatovich P; Hoekman B; Govorukhina N; Bischoff R
J Sep Sci; 2010 Jun; 33(10):1421-37. PubMed ID: 20486207
[TBL] [Abstract][Full Text] [Related]
36. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma.
Ohshiro K; Rosenthal DI; Koomen JM; Streckfus CF; Chambers M; Kobayashi R; El-Naggar AK
Int J Oncol; 2007 Mar; 30(3):743-9. PubMed ID: 17273777
[TBL] [Abstract][Full Text] [Related]
37. Statistical identification of differentially labeled peptides from liquid chromatography tandem mass spectrometry.
Cho H; Smalley DM; Theodorescu D; Ley K; Lee JK
Proteomics; 2007 Oct; 7(20):3681-92. PubMed ID: 17879999
[TBL] [Abstract][Full Text] [Related]
38. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis.
Liao H; Wu J; Kuhn E; Chin W; Chang B; Jones MD; O'Neil S; Clauser KR; Karl J; Hasler F; Roubenoff R; Zolg W; Guild BC
Arthritis Rheum; 2004 Dec; 50(12):3792-803. PubMed ID: 15593230
[TBL] [Abstract][Full Text] [Related]
39. An exclusion list based label-free proteome quantification approach using an LTQ Orbitrap.
Muntel J; Hecker M; Becher D
Rapid Commun Mass Spectrom; 2012 Mar; 26(6):701-9. PubMed ID: 22328225
[TBL] [Abstract][Full Text] [Related]
40. An integrated serum proteomic approach capable of monitoring the low molecular weight proteome with sequencing of intermediate to large peptides.
Merrell K; Thulin CD; Esplin MS; Graves SW
Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2685-96. PubMed ID: 19630037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
